211 related articles for article (PubMed ID: 708106)
1. Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis.
Schaub J; Däumling S; Curtius HC; Niederwieser A; Bartholomé K; Viscontini M; Schircks B; Bieri JH
Arch Dis Child; 1978 Aug; 53(8):674-6. PubMed ID: 708106
[TBL] [Abstract][Full Text] [Related]
2. Atypical phenylketonuria caused by 7, 8-dihydrobiopterin synthetase deficiency.
Niederwieser A; Curtius HC; Bettoni O; Bieri J; Schircks B; Viscontini M; Schaub J
Lancet; 1979 Jan; 1(8108):131-3. PubMed ID: 84153
[TBL] [Abstract][Full Text] [Related]
3. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.
Niederwieser A; Curtius HC; Wang M; Leupold D
Eur J Pediatr; 1982 Mar; 138(2):110-2. PubMed ID: 7094929
[TBL] [Abstract][Full Text] [Related]
4. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency.
Smith I; Hyland K; Kendall B
J Inherit Metab Dis; 1985; 8 Suppl 1():39-45. PubMed ID: 3930840
[TBL] [Abstract][Full Text] [Related]
5. Malignant phenylketonuria due to defective synthesis of dihydrobiopterin.
Cohen BE; Szeinberg A; Quint J; Normand M; Blonder J; Peled I
Isr J Med Sci; 1985 Jun; 21(6):520-5. PubMed ID: 3874852
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of tetrahydrobiopterin deficiency.
Niederwieser A; Ponzone A; Curtius HC
J Inherit Metab Dis; 1985; 8 Suppl 1():34-8. PubMed ID: 3930839
[TBL] [Abstract][Full Text] [Related]
7. Atypical phenylketonuria due to biopterin deficiency. Early treatment with tetrahydrobiopterin and neurotransmitter precursors, trials of monotherapy.
Endres W; Niederwieser A; Curtius HC; Wang M; Ohrt B; Schaub J
Helv Paediatr Acta; 1982; 37(5):489-98. PubMed ID: 6761317
[TBL] [Abstract][Full Text] [Related]
8. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
[TBL] [Abstract][Full Text] [Related]
9. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain.
Kaufman S; Kapatos G; McInnes RR; Schulman JD; Rizzo WB
Pediatrics; 1982 Sep; 70(3):376-80. PubMed ID: 7110811
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperphenylalaninemia--clinical features, biochemical findings, and experience with administration of biopterins.
Danks DM; Schlesinger P; Firgaira F; Cotton RG; Watson BM; Rembold H; Hennings G
Pediatr Res; 1979 Oct; 13(10):1150-5. PubMed ID: 503643
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin responsiveness in a large series of phenylketonuria patients.
Weglage J; Grenzebach M; von Teeffelen-Heithoff A; Marquardt T; Feldmann R; Denecke J; Gödde D; Koch HG
J Inherit Metab Dis; 2002 Aug; 25(4):321-2. PubMed ID: 12227464
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of phenylketonuria with tetrahydrobiopterin.
Trefz FK; Aulela-Scholz C; Blau N
Eur J Pediatr; 2001 May; 160(5):315. PubMed ID: 11388602
[No Abstract] [Full Text] [Related]
13. Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria.
Danks DM; Cotton RG; Schlesinger P
Lancet; 1975 Nov; 2(7943):1043. PubMed ID: 53532
[No Abstract] [Full Text] [Related]
14. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
Fiege B; Blau N
J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.
Kaufman S; Kapatos G; Rizzo WB; Schulman JD; Tamarkin L; Van Loon GR
Ann Neurol; 1983 Sep; 14(3):308-15. PubMed ID: 6139056
[TBL] [Abstract][Full Text] [Related]
16. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
[TBL] [Abstract][Full Text] [Related]
17. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.
Michals-Matalon K
Expert Opin Investig Drugs; 2008 Feb; 17(2):245-51. PubMed ID: 18230057
[TBL] [Abstract][Full Text] [Related]
18. Biopterin defect in a normal-appearing child affected by a transient phenylketonuria.
Rey F; Leeming RJ; Blair JA; Rey J
Arch Dis Child; 1980 Aug; 55(8):637-9. PubMed ID: 7436521
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience.
Mitchell JJ; Wilcken B; Alexander I; Ellaway C; O'Grady H; Wiley V; Earl J; Christodoulou J
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S81-5. PubMed ID: 16091307
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.
Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
